VANGUARD GROUP INC - ZYVERSA THERAPEUTICS INC ownership

ZYVERSA THERAPEUTICS INC's ticker is and the CUSIP is 98987D102. A total of 7 filers reported holding ZYVERSA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ZYVERSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,227
-47.2%
17,1940.0%0.00%
Q2 2023$4,221
-87.1%
17,194
+1.8%
0.00%
Q1 2023$32,60516,8940.00%
Other shareholders
ZYVERSA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Winthrop Advisory Group LLC 13,361$25,7870.01%
VANGUARD GROUP INC 16,894$32,6050.00%
UBS Group AG 3,282$6,3340.00%
WELLS FARGO & COMPANY/MN 28$540.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GOLDMAN SACHS GROUP INC 103,471$199,6990.00%
Tower Research Capital LLC (TRC) 4,663$90.00%
View complete list of ZYVERSA THERAPEUTICS INC shareholders